CDKN2A and neoplasm: In total, 8 (80%) CID genes showed differential expression, CDKN2A showed significant upregulation, and seven CID genes showed significant downregulation in the tumor samples (Figure 1D, p < 0.05, one-sided Wilcoxon rank-sum test).